Founder, Barbara Ryan Advisors
Barbara Ryan is the Founder of Barbara Ryan Advisors, a healthcare capital markets strategic advisory firm. Formerly, Barbara was a Managing Director at FTI Consulting and lead the firms Healthcare and Life Sciences Capital Markets practice in the Strategic Communications Division. In that capacity, Barbara has provided strategic counsel and tactical support on several of the highest profile deals in the biopharma industry in 2014, and the best performing IPO of the year. Her clients include Cardinal Health, Purdue, Zoetis, Radius Health, OPKO, Shire, Allergan, and Perrigo.
Ms. Ryan has more than 31 years of Wall Street experience as a sell-side research analyst covering the biopharmaceutical sector and providing financial analysis and industry expertise to institutional clients. Ms. Ryan’s opinions and expertise are widely sought; she is frequently quoted in the press and is a Guest Contributor for CNBC.
For 19 years prior to joining FTI Consulting, Ms. Ryan was a Managing Director at Deutsche Bank and Head of the company’s Pharmaceutical Research Team. She is widely recognized as an authority on the trends and outlook for the global pharmaceutical industry and has been publishing her analysis throughout her career. Ms. Ryan also served as the lead analyst on several high profile IPOs such as Express Scripts, PSSI, Flamel Technologies, and Henry Schein.
Ms. Ryan currently serves on Pharmaceutical Executive ‘s Editorial Advisory Board, the Executive Advisory Board for the Prix Galien Foundation, is a member of the Life Sciences Council of Springboard Enterprises, and is a member of the Faculty at the GLG Institute. Ms. Ryan has been a guest lecturer at top university MBA programs including Columbia and University of California at Berkeley. Barbara is Chair of the Board of Villa Maria School for children with learning disabilities in Stamford, Ct.
Ms. Ryan majored in finance at the University of Massachusetts at Amherst.